Stock PRCT PROCEPT BIOROBOTICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News PROCEPT BioRobotics Corporation

Equities

PRCT

US74276L1052

Market Closed - Nasdaq
Other stock markets
 01:30:00 01/06/2024 am IST 		5-day change 1st Jan Change
66.4 USD +3.39% Intraday chart for PROCEPT BioRobotics Corporation -0.75% +58.43%
15/05 Transcript : PROCEPT BioRobotics Corporation Presents at Bank of America Health Care Conference 2024, May-15-2024 09:20 AM
06/05 Piper Sandler Adjusts Price Target on PROCEPT BioRobotics to $75 From $67, Maintains Overweight Rating MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PROCEPT BioRobotics : Leerink Partners Healthcare Crossroads Conference 2024
PU
PROCEPT BioRobotics : AUA 2024 Investor Presentation
PU
PROCEPT BioRobotics : 2024 Bank of America Heathcare Conf
PU
Transcript : PROCEPT BioRobotics Corporation Presents at Bank of America Health Care Conference 2024, May-15-2024 09:20 AM
PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference
GL
Piper Sandler Adjusts Price Target on PROCEPT BioRobotics to $75 From $67, Maintains Overweight Rating
MT
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
GL
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
AQ
PROCEPT BioRobotics Corporation Announces Long-Term, Real-World Data Showing the Benefits of Aquablation Therapy for the Treatment of Symptomatic Prostatic Hyperplasia
CI
Procept BioRobotics Insider Sold Shares Worth $1,200,000, According to a Recent SEC Filing
MT
Procept BioRobotics Insider Sold Shares Worth $1,916,428, According to a Recent SEC Filing
MT
PROCEPT BioRobotics : AUA 2024 Investor Presentation
PU
PROCEPT BioRobotics : 2024 AUA Investor Day
PU
Transcript : PROCEPT BioRobotics Corporation - Analyst/Investor Day
Truist Raises PROCEPT BioRobotics' PT to $72 From $63 After 'Solid' Q1 Beat, Keeps Buy Rating
MT
PROCEPT BioRobotics : Q1 2024 Procept BioRobotics Earnings Conference Call
PU
PROCEPT BioRobotics : Investor Presentation – May 2024
PU
Procept BioRobotics Shares Rise After Q1 Loss Narrows, Revenue Increases; 2024 Revenue Guidance Revised
MT
Transcript : PROCEPT BioRobotics Corporation, Q1 2024 Earnings Call, May 01, 2024
PROCEPT BioRobotics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PRCT Stock
  4. News PROCEPT BioRobotics Corporation